Key result
Systemic thrombolysis with tissue plasminogen activator successfully resolved extensive bilateral pulmonary artery thrombi and right ventricular hypertension in a critically ill neonate.
Why the study?
Pulmonary artery thromboembolism is rare in children and can result in significant morbidity and mortality if undiagnosed.
Case Report (n=1)
No
Answers are grounded in this paper and cite their sources.
Tissue plasminogen activator can be successfully used for thrombolysis in neonates with severe pulmonary artery thromboembolism.
Pulmonary artery thromboembolism is a common and treatable cause of adult pulmonary hypertension. Although rare in children, if undiagnosed, it can result in significant morbidity and mortality. We report a case of a cyanotic neonate found to have bilateral pulmonary arterial thrombi who successfully underwent thrombolysis using tissue plasminogen activator with prompt resolution of right ventricular hypertension.
No takes yet. Share an insight, caveat, or question.
Villeda et al. (2021) conducted a case report in Pulmonary artery thromboembolism (n=1). Tissue plasminogen activator (tPA) was evaluated on Resolution of pulmonary artery thrombi and right ventricular hypertension. Systemic thrombolysis with tissue plasminogen activator successfully resolved extensive bilateral pulmonary artery thrombi and right ventricular hypertension in a critically ill neonate.
Synapse has enriched 10 related papers. Consider them for comparative context: